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ABSTRACT
Introduction: Hypertensive Disorders of Pregnancy are common and may result in increased 
maternal and neonatal morbidity and mortality. Multiple pregnancies confer an increased risk of 
development of a hypertensive disorder of pregnancy. The purpose of this study was to examine a 
large cohort of women delivering a multiple pregnancy in a single large tertiary unit, and to 
evaluate the implications of hypertensive disorders of pregnancy on both maternal and perinatal 
outcomes. Material and methods: Retrospective study of all twin pregnancies delivered at Cork 
University Maternity Hospital, Ireland over a 9-year period (2009–2017). The twin pregnancies 
were divided according to the presence or absence of hypertensive disorder of pregnancy and the 
two groups compared. Results: Maternal age >40 years, nulliparity, conception through use of a 
donor oocyte, and presence of obstetric cholestasis are all risk factors for the development of 
Hypertensive Disorders of Pregnancy in women with a multiple pregnancy. When a hypertensive 
disorder complicates a twin pregnancy, it increases the incidence of iatrogenic late prematurity & 
neonatal hypoglycaemia. Conclusions: This study is informative for clinicians caring for women 
with a multiple pregnancy with its relevant data on perinatal outcomes following a diagnosis of 
hypertensive disorder in pregnancy. 
Keywords
Hypertensive disorder of pregnancy, multiple pregnancy, twin pregnancy, pre-eclampsia, 
gestational hypertension
Abbreviations
ART -assisted reproductive techniques 
CUMH -Cork University Maternity Hospital 
HDP -hypertensive disorder of pregnancy
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aOR adjusted odds ratio 
CI confidence interval
IVF in vitro fertilization 
Key Message
Hypertensive disorders of pregnancy in multiple pregnancies are more frequent in nulliparous 
women aged greater than forty, conceiving through use of a donor oocyte. Iatrogenic late 
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INTRODUCTION
Variation exists between international bodies on the exact classifications of hypertensive disorders 
of pregnancy (HDP), but general consensus agrees that they can broadly categorised as follows; 
chronic hypertension of all causes, gestational (non-proteinuric) hypertension, pre-eclampsia and 
superimposed pre-eclampsia (1). The potential complications that may occur in a pregnancy 
affected by a hypertensive disorder directly relate to the underlying pathology of the condition. 
Late onset gestational hypertension is generally a benign condition with minimal increased risk to 
mother or baby (2). In contrast, early onset severe pre-eclampsia can confer a risk of morbidity, as 
well as mortality, especially in developing countries (3). 
Multiple pregnancy occurs spontaneously in approximately one in 80 pregnancies (4). Both 
increasing maternal age and access to assisted reproductive techniques (ART) have had an impact 
in the number of twin pregnancies globally, with a dramatic increase reported over the past several 
decades (5, 6). Multiple births account for approximately 3% of live births (7). Figures from the 
Central Statistics Office show the number of twins born in Ireland has increased from 10.5 per 
1,000 live births in 1985, to 18.6 per 1,000 in 2015, with an increase of 22.5% over the last decade 
alone (8). Similar trends are reported in other countries (9, 10). Multiple pregnancy confers 
increased perinatal risk, including mortality, preterm birth, congenital abnormalities, fetal growth 
restriction and twin-twin transfusion syndrome (10). Further, many maternal obstetric morbidities, 
such as anaemia,  haemorrhage, gestational diabetes mellitus and obstetric cholestasis (OC), arise 
more commonly in the setting of multiple gestation (10, 11). In the latest (2016) annual report 
from the national perinatal epidemiology centre (NPEC), multiple pregnancy was associated with 
an almost fourfold increased risk of severe maternal morbidity (12).
Multiple pregnancy is known to be a risk factor for the development of HDP, with a reported 
incidence ranging from 13-37%, which is 2-3 times higher than that seen in singletons (13). Most 
studies to date have focused on the risk factors for the development of HDP in a multiple 
pregnancy cohort (14), but reports on the clinical outcomes when these complications arise are 
fewer. Studies have suggested that multiple pregnancy complicated by HDP has a higher incidence 
of adverse pregnancy outcomes, specifically; pre-term delivery, small for gestational age infants, 
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reported that when these complications arise, they are likely to occur at an earlier gestation in 
multiple pregnancy compared to singleton pregnancy, which further increases potential perinatal 
morbidity (16). The aim of this study was to review a large cohort of women delivering a multiple 
pregnancy in a single large tertiary unit, and to evaluate the implications of HDP on both maternal 
and perinatal outcomes. 
MATERIAL AND METHODS
This was a retrospective study of all twin pregnancies delivered at Cork University Maternity 
Hospital (CUMH), Ireland over a 9-year period (2009–2017). All women attending CUMH had a 
booking appointment and dating ultrasound performed between 11-13 weeks gestation.  If the 
dating scan identified a multiple pregnancy, chorionicity was immediately determined and the 
women referred to the hospital’s dedicated multiple pregnancy clinic. A Maternal-Fetal Medicine 
(MFM) specialist consultant, experienced in the management of multiple pregnancy, directs the 
clinic and creates a unique management plan for each patient dependent on their obstetric history 
and personal preferences. A dedicated midwife sonographer for multiple pregnancy saw all 
women and performed ultrasounds in accordance to a routine scan schedule as per national 
guidelines (17) to assess for evolving growth discrepancy or twin-twin transfusion syndrome. In 
Ireland women have the option of public or private antenatal care. Those attending privately had a 
consultant obstetrician of their choice review them at each visit and the same Consultant present to 
oversee the delivery. Those attending the public multiple pregnancy clinic in CUMH were under 
the care of a single Consultant Obstetrician and their team of non-consultant hospital doctors 
(NCHD). All multiple pregnancy births in CUMH are attended by an obstetrician; for public 
patients this is the Obstetrician assigned to cover the labour ward on the day of the delivery.  
Outcome Measures
Maternal obstetric information was obtained from obstetric charts, hospital birth registers, 
ultrasound reports and laboratory data.  Demographic data included; maternal age and body mass 
index (BMI) at booking, parity, mode of conception (spontaneous conception vs. all ART and type 
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based on ultrasound findings at 11-13 weeks gestation; this was reviewed in charts and after birth 
for confirmation of scan findings. Gestation at delivery, onset of labour (i.e. spontaneous or 
induced labour) mode of delivery and indications for induction/assisted delivery were also 
captured. 
Specific maternal outcome measures were; OC (pruritus with deranged liver transaminases (>70 
U/L) with elevated fasting serum bile acids (>10mmol/L)), gestational diabetes (diagnosed by oral 
glucose tolerance test at 24 - 28 weeks’ gestation) or presence of a hypertensive disorder of 
pregnancy; either pre-eclampsia or gestational hypertension. Pre-eclampsia was defined as; 
“sustained hypertension with systolic blood pressure ≥ 140 or diastolic blood pressure ≥ 90 (on at 
least two occasions at least 4hrs apart) with significant quantified proteinuria (>300mg protein on 
24hr collection or urine protein creatinine ratio >30mg/mmol or ≥ 3+ on dipstick urinalysis)” 
occurring after 20 weeks’ gestation. Gestational hypertension was defined as “persistent blood 
pressure readings ≥140/90 mmHg, without associated proteinuria” occurring after 20 weeks’ 
gestation. 
Perinatal outcomes were obtained from birth records, neonatal charts and the neonatal intensive 
care unit (NICU) database. Specific perinatal outcome measures included; Stillbirth of one twin 
(24 weeks’ gestation and/or weighing 500 g or more), suspected small for gestational age (defined 
as an estimated fetal weight less than tenth percentile for gestational age, detected antenatally on 
ultrasound based on accurate dating) (18), Prematurity (defined as birth occurring at less than 37 
weeks’ gestation) and the degree of prematurity; very preterm (<32 weeks’ gestation), moderately 
preterm (32+1–33+6 weeks’ gestation) and late preterm (34–36+6 weeks’ gestation). 
Other parameters recorded were; Birth weight (measured in grams), presence of a low Apgar score 
(defined as <7 at 1 minute or <7 at 5 minutes), NICU admission and the length of stay (days) in 
the NICU. The possible  indications for NICU admission were; prematurity, low birth weight, 
small for gestational age at birth (birthweight <10th customised centile), suspected infection, poor 
feeding, apnoea of the newborn, transient tachypnoea of the newborn (TTN), respiratory distress 
syndrome (RDS), hypothermia, hypoglycaemia or other. t. Complications in the neonatal period 
included any of the following; respiratory, haematological, hypoglycaemia, jaundice, respiratory 
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Serious neonatal morbidity was not frequent. A composite measure of perinatal morbidity was 
chosen and included the following: hypoxic ischaemic encephalopathy of any grade (HIE), 
necrotising enterocolitis of any grade (NEC), intraventricular haemorrhage grade two or higher 
(IVHG2) or sepsis (based on positive blood cultures or cerebrospinal fluid). 
Statistical Analyses
Initially the entire cohort was examined for trends, and then the twin pregnancies were divided 
according to the presence or absence of hypertensive disorder of pregnancy and the two groups 
compared. Descriptive and inferential statistics were employed to analyse the data utilising SPSS 
version 23 (IBM Corp., Armonk, NY, USA). Differences between the hypertensive and non-
hypertensive groups were compared using Chi square tests and t-tests where appropriate. Logistic 
regression analysis was used to assess the impact of HDP on the likelihood of outcomes. Adjusted 
analysis, for known risk factors for HDP such as maternal BMI >35 Kg/m2, maternal age >40 
years and nulliparity, in accordance with  national clinical guidelines (19) was also employed. 
Monochorionic twins are more frequently associated with congenital anomalies as well as having 
an inherently increased risk of adverse perinatal outcomes when compared with dichorionic twins 
(20). Therefore, the analysis was then repeated with the monochorionic twin pregnancies removed 
from the cohort to examine their influence.   
Ethical Approval
Ethical Approval for the study was granted by the Cork Research Ethics Committee (ECM 4 (zz) 
05/06/18).
RESULTS
One thousand five hundred and sixty six women (n=1566) delivered a multiple pregnancy in 
CUMH from the 1st January 2009 until the 31st December 2017. The majority of the group were 
dichorionic twin pregnancies (81.2%; n=1271). Almost a fifth of these (17%; n=270) were 
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15% among the monochorionics. Three thousand one hundred and thirty two neonates (n=3132) 
were delivered from these pregnancies, with the vast majority (98%; n=3078) of these delivered 
live born. 
Maternal Demographics (Table 1)
The maternal and pregnancy characteristics of the twin pregnancies included in the study are 
shown in Table.  
When comparing those that developed HDP against those that did not, those that developed a HDP 
were twice as likely to be greater than 40 years of age (adjusted odds ratio (aOR) 2.3, 95% 
confidence interval (CI) 1.1-4.69) and more than twice as likely to be nulliparous (aOR 2.6, 
95%CI 1.6-4.4). There was no difference in the incidence of HDP between public and private 
antenatal care (aOR 2.3, 95%CI 0.8-6.4), BMI >35 Kg/m2 (aOR 2.0, 95%CI 0.8-5.0) nor with 
placental chorionicity (aOR 0.8, 95%CI 0.4-1.7). Overall, the incidence of HDP was not increased 
by the use of ART (aOR 1.4, 95%CI 0.8-2.4). However, when ART was examined by mode of 
conception, oocyte donation conferred a threefold increased risk of HDP (aOR 2.7, 95%CI 1.4-
5.3) while with ovulation induction (any medication without use of in vitro fertilization (IVF)) it 
was eight times more likely to occur (aOR 8.1, 95%CI 2.5-26.5).
Maternal Outcomes (Table 1)
Overall, the incidence of gestational diabetes mellitus and OC were 7.9% and 6% respectively. 
Concomitant gestational diabetes mellitus and OC occurred in just 1% (n=16).  Diagnosis of 
gestational diabetes mellitus did not increase the likelihood of a diagnosis of HDP (aOR 1.1, 
95%CI 0.4-2.7) however women with OC were almost four times more likely to develop HDP, 
even when  adjusted for confounding risk factors (aOR 3.7, 95%CI 1.3-10.3). Antenatal steroids 
for fetal lung maturation were administered to over a quarter of women (28.5%, n=447). When the 
group was dichotomised by the presence or absence of HDP, those with HDP were almost twice as 










This article is protected by copyright. All rights reserved
Onset of labour and mode of delivery (Table 2)
Delivery was by pre-labour caesarean for almost half the cohort (49.6%, n=1553), with the 
mothers of a third of the babies having a spontaneous onset of labour (30%, n=941). Overall two 
thirds of the cohort delivered by caesarean section (66.8%, n=2092 
No differences were noted in terms of onset of labour, indication for caesarean section or grade of 
caesarean section when the two groups were compared. Analysis on mode of delivery revealed the 
HDP group to be three times more likely to undergo an emergency caesarean in labour (aOR 2.9, 
95%CI 1.1-3.20) compared to having a spontaneous vaginal delivery. The HDP group was less 
likely to have a vaginal breech delivery (aOR 0.5, 95%CI 0.3-0.8) or an elective caesarean 
delivery (aOR 0.5, 95%CI 0.2-0.9). We found that the HDP group were nine times more likely to 
require an emergency caesarean section for delivery of the second twin (aOR 9.0, 95%CI 1.4-58.9) 
however it is important to note that the number in this group is very small. 
Preterm delivery (Table 3 & Table 4)
Over half (57.2%, n=1761) of all live-born twins in the study delivered pre-term with the aetiology 
for the prematurity shown in Table 3. Comparing the two groups, those with HDP were more than 
twice as likely to deliver preterm (aOR 2.5, 95%CI 1.6-3.7). A difference in gestational age 
between the two groups only existed at 34-36+6 weeks gestation with the HDP group almost three 
times more likely to deliver then (aOR 2.9, 95%CI 1.9-4.3). Induction of labour was five times 
more likely (aOR 4.9, 95%CI 2.8-8.7) while emergency pre-labour caesarean delivery was 
increased fourfold (aOR 3.9, 95%CI 2.3-6.6) in the HDP group with premature delivery compared 
to controls. Delivery prior to 37 weeks is not uncommon for monochorionic twins. When 
monochorionic pregnancies were removed and the analysis repeated the conclusions were 
unchanged (Table 4). 
Perinatal outcomes (Table 5 & Table 6)
Perinatal outcomes for the entire twin pregnancies’ study (n=3132) are shown in Table 5. Just over 
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ultrasound (estimated fetal weight <10th gestational centile using the Hadlock formula). Low birth 
weight (<2500g) was present in almost half of cases (49%, n=1527) but very low birth weight 
(<1500g) occurred in very few (7.7%, n=242). Fetal anomaly was present in approximately one in 
twenty cases (6%, n=190). After birth the incidence of small for gestational age was 2.7% among 
women with HDP compared to 3.5% among women without HDP. Of those babies born alive 
(98%, n=3078) admission to the NICU occurred in almost half (42.6%, n=1333), with prematurity 
(77.6%, n=1027) and low birth weight (<2500g) (59.8%, n=800) being the main reasons for 
admission. Length of stay was beyond 14 days in almost half of those admitted (48.6%, n=648). 
Respiratory (37.3%, n=1167) and haematological (28.6%, n=337) complications were the most 
commonly occurring in the neonatal period. A composite measure of neonatal morbidity was low 
(4.6%, n=140). 
The incidence of perinatal mortality for the group was low (1.2%, n=39).  This figure reflects the 
combination of intrauterine (1%, n=31) and neonatal (0.9%, n=29) deaths that occurred in the 
study. The corrected perinatal mortality rate for the entire cohort was 12.3, 5.4 for the dichorionic 
group and 41.0 for the monochorionic group. 
Rates of  low Apgar scores, mean birth weight and fetal anomaly did not differ between the two 
groups (Table 5).  Low birth weight was four times more frequent in the HDP group compared to 
the non-HDP group (aOR 3.9, 95%CI 2.3-6.6). Requirement for NICU and length of stay in NCU 
did not differ either. Indication for admission to the NICU was similar between both groups.  HDP 
was protective against admission for suspected infection (aOR 0.5, 95%CI 0.3-0.9) while apnoea 
of the newborn was three times more likely in the presence of HDP (aOR 3.0, 95%CI 1.0-8.7). 
Overall, complications in the neonatal period were similar for both groups with no difference in 
the composite measure of neonatal morbidity. However significant difference were noted in the 
incidence of hypoglycaemia with a threefold (aOR 3.3, 95%CI 2.5-7.3) increase respectively seen 
when HDP was present. Perinatal mortality was not common and although a trend towards lower 
mortality was present in the HDP, low numbers prevented comparative analysis between the two 
groups. When monochorionic pregnancies were removed and the analysis repeated the conclusions 
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This study highlights that nulliparity, maternal age over 40 years, conception though use of donor 
oocyte and presence of OC are important risk factors for the development of HDP with a multiple 
pregnancy. It also outlines that when HDP does complicate a multiple pregnancy, it more 
commonly results in iatrogenic late premature delivery and neonatal hypoglycaemia. 
Almost a fifth of our twin cohort developed a HDP. This rate is in keeping with the higher 
incidence of HDP quoted in the literature for multiples; usually in the order of a 3 fold increased 
risk for pre-eclampsia alone. This rate may even be an underestimation, with a recent study 
comparing incidence of pre-eclampsia  in gestationally matched singletons to twins, all at <37 
weeks, reporting a nine fold increased risk of pre-eclampsia  in twins (21). The reason behind this 
increased risk of HDP in multiple pregnancy is not fully understood, but is likely due to a 
combination of maternal risk factors and the presence of a larger placental mass; which may 
predispose to an angiogenic imbalance. Circulating angiogenic factors, such as placental growth 
factor (PlGF) and its soluble receptor sFlt-1 are well described as being significantly altered in 
women prior to the clinical onset of pre-eclampsia (22, 23). With a larger placenta comes higher 
levels of these circulating angiogenic factors, and studies have shown increased risk of pre-
eclampsia with each for each two fold elevation in sFlt-1 (24). Prediction of pre-eclampsia using 
these angiogenic factors is a topical presently however their utility in aiding diagnoses of pre-
eclampsia in multiple pregnancy warrants further research (25, 26). 
Maternal age >40 years, nulliparity and conception through use of a donor oocyte are all well-
established risk factors for HDP in both singleton and multiple pregnancies (27). Over the last 
number of decades, use of ART has increased  and pregnancy through use of donor oocyte is now 
common (28). The popular media portrayal of ART is that it is a viable risk free option for 
achieving pregnancy at any age with little recognition is given to the increased risks associated 
with pregnancy at an older age or through use of ART (29).  
The higher incidence of HDP in our cohort in those conceiving through ovulation induction needs 
to be interpreted with caution as the numbers are small (n=22) and when adjusted the confidence 
interval is very large. We did observe significantly more HDP when conception arose through use 
of a donor oocyte which is well described by other studies in both singletons and multiples (30, 
31). It is worth noting that mode of conception in our cohort is self-reported by women at their 
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ART sector needs regulation and protocols aimed at minimising the risk of multiple pregnancy 
should be advocated (32). Internationally, countries which have had success increasing their rates 
of single embryo transfer such as Belgium, Norway and Denmark have generous IVF state 
funding (33).  Introduction of state funding, and consequently access to multiple fresh and frozen 
IVF cycles, was also seen to radically reduce the rate of multiple embryo transfer province in 
Quebec (34).
Our study found no difference in the incidence of HDP between either monochorionic or 
dichorionic twin pregnancies. The relationship between chorionicity and HDP is unclear and 
sometimes conflicting. A study in 2016 showed dichorionicity to be an independent risk factor for 
the development of pre-eclampsia but not gestational hypertension (35) while other studies have 
reported no association between chorionicity and hypertensive disease (14). Ideally, we would like 
to examine our cohort further by comparing chorionicity against type of HDP present but a 
limitation of our study is that this is not possible from our data. 
A number of studies have reported higher incidence of hypertensive disease with increased 
maternal BMI and the protective effect against this seen with the use of aspirin (36). Practice on 
use of aspirin in our unit did not change during the time-period of this review. Women with pre-
existing medical co-morbidities (such as hypertension, renal disease, lupus or antiphospholipid 
syndrome) or concomitant moderate risk factors (IVF, oocyte donation, maternal age >40 years, 
BMI >30 Kg/m2 or previous poor obstetric history) were prescribed aspirin 75mg once daily from 
their booking visit in line with national guidelines (19). Unfortunately, a significant limitation of 
the study is the lack of data on use of aspirin in women in our cohort, limiting analysis on the 
influence of this factor in our population. 
Our study reports an almost fourfold likelihood of OC in multiple pregnancies complicated by 
HDP. This predilection for the development of pre-eclampsia with OC is a relatively new concept, 
with the majority of studies to date reporting on singleton pregnancies (11, 37). Some research has 
suggested that the pathological mechanisms causing hepatic impairment in women with pre-
eclampsia may predispose to cholestasis (38). Further research is warranted to assess if it is the 
same mechanism responsible in cases of multiple pregnancy. With this evolving knowledge of the 
predisposition for HDP in those with OC, it is reasonable for clinicians to consider increased 
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The overall incidence of vaginal breech birth was an interesting finding of the study. Since 
publication of the Term Breech trial almost twenty years ago, (39) vaginal breech birth in high 
income countries generally only occurs in cases  of a second twin delivery or premature delivery. 
Our findings illustrate that for every vaginal twin birth that occurred, 1 out of  5 second twins were 
delivered breech.
HDP is recognised as arising on a background of placental dysfunction, thus those with HDP may 
have a reduced capacity for placental function when labouring and may require expedited delivery 
(40). This is a potential explanation for the increased likelihood of caesarean section in labour and 
caesarean section for second twin that was noted in women with HDP in our cohort.  Although a 
higher incidence of preterm delivery was noted in the HDP group, differences in gestational age at 
delivery was only significant at later pre-term gestation (34-36+6 weeks). This likely reflects an 
overall later onset of HDP in our cohort which is in contrast to many studies that have reported 
HDP to arise earlier in multiples than in singletons (14, 16, 41). It is well described that early 
onset pre-eclampsia (<34 weeks) is more severe and frequently results in poorer perinatal 
outcomes (42, 43).  A limitation of our study is the lack of knowledge of gestational age at time of 
diagnosis of HDP. 
Given the population under review it is not surprising a high incidence of administration of 
antenatal steroids for fetal lung maturation was present however the increased incidence of 
administration when HDP was present reflects the increased risk of premature delivery it confers. 
The prematurity noted in the HDP group of our cohort was iatrogenic in nature. Other studies have 
reported similar findings (13, 15), highlighting the potential for fetal and/or maternal morbidity 
and requirement for medical intervention when HDP complicates a multiple pregnancy. The 
higher incidence of low birth weight babies with HDP correlates with the higher rates of pre-
maturity seen while the similar rates of very low birth weight babies supports the prematurity 
arising  at a later gestational age. 
Overall the perinatal outcomes between the HDP groups were largely comparable. A composite 
measure of perinatal morbidity did not show any difference between the two groups, a similar 
finding to other researchers (44). We noted an increased incidence of neonatal hypoglycaemia in 
the infants born to women with a HDP. A number of papers have reported an association between 
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steroids is important with late administration of steroids (≥34 weeks ) associated with a 2-fold 
higher risk of neonatal hypoglycaemia compared to early administration (<34 weeks) (47). 
Potentially this may be the cause of the hypoglycaemia noted however neonatal hypoglycaemia 
has also been linked with maternal administration of beta-blockers in late pregnancy (48). 
Labetalol, a beta-blocker, is the first line anti-hypertensive medication utilised in our unit. Use of 
labetalol or another anti-hypertensive and the gestational age when administration of antenatal 
steroids occurred, are data points unfortunately not recorded for our cohort. This is a limiting 
factor of our study however it does highlights a potential area for future prospective research. 
Presence of HDP conferred a protective effect against admission to the NICU for reasons of 
suspected infection. Infection in multiples most usually arises in the case of premature 
spontaneous onset of labour (49). Given that prematurity in the HDP group in our cohort was 
iatrogenic, it would be in keeping with less likelihood of infection. 
A retrospective study by a group of Irish researchers focusing on multiple pregnancies from 1996-
2012 has shown a reduction in overall perinatal mortality with multiple pregnancy over the 17 
year period examined (50). In our study a trend towards higher incidence of perinatal mortality in 
the non-hypertensive group was noted, however the numbers are too small to allow a meaningful 
comparison. A US retrospective study of over 250,000 multiple pregnancies published in 2014 
postulated gestational hypertension to be beneficial for fetal survival in twin pregnancies, but 
advocated further prospective studies be conducted to assess for confounding variables (51). 
Limitations of this study are included in our discussion. In summary the absence of some 
population data (eg; type of HDP diagnosed, use of aspirin or anti-hypertensive agents or women 
transferred in from a peripheral unit), given that it was conducted retrospectively, limits analysis 
and comparison to other published work. Ideally, to fully appreciate the impact of HDP in multiple 
pregnancy it would be sensible to compare our outcomes to those of singleton pregnancies 
affected by HDP in women in our unit during the same time-period. Unfortunately, we do not have 
this information available to us and it is not feasible to obtain, therefore we must rely on the 
published work of others for comparative purposes. The strength of this work is that it is a 
collective of nine years’ worth of obstetric data from a tertiary maternity unit, with over 8000 
deliveries annually and availability of a large neonatal outcome database. The unit also has a 
dedicated multiple pregnancy clinic, which has been advocated in order to harmonise management 
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CONCLUSION
In summary, we examined a large cohort of women with a multiple pregnancy to look at the 
incidence of HDP and their impact on perinatal outcomes. Women must be appropriately 
counselled by healthcare professionals in relation to potentially increased risks when embarking 
on a pregnancy at an advanced age, especially through use of ART and/or donor oocyte. It is 
imperative that women who do conceive multiples, especially if they are older or have medical co-
morbidities, are risk assessed and appropriately referred antenatally for more intense maternal and 
fetal screening and surveillance. Early recognition of complications allows referral to an 
experienced clinician, ideally within a dedicated multiple pregnancy clinic, and appropriate 
management employed.  Should a hypertensive disorder occur in a twin pregnancy, it is 
encouraging from this study to note perinatal outcomes overall were good. This information may 
be useful when counselling patients antenatally.
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Table 1: Maternal characteristics and antenatal complications according to presence of hypertensive disorder of pregnancy 
(HDP).
Maternal Characteristics Total population 
(n = 1566)b
HDP 
(n = 270) b
No HDP 





Age Range (years) 17-51 18-51 17-51 - -
Maternal Age >35 years 766 (48.9) 142 (52.6) 624 (48.1) 1.18 (0.9-1.5) -
Maternal Age >40 years 173 (11) 43 (15.9) 130 (10) 1.6 (1.1-2.4) 2.3 (1.1-4.6)















































































































Antenatal Steroids 447 (28.5) 99 (36.7) 348 (26.9) 1.5 (1.1-2.0) 1.7 (1.0-2.8)
aAdjusted Odds Ratio (for BMI >35 Kg/m2, Maternal Age >40 and Nulliparity). Results demonstrating significant differences are highlighted in bold.
bValues are shown in n (%) unless otherwise stated
cReference is Spontaneous Conception.
dReference is no Antenatal Complication
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Table 2: Mode of delivery
Total population 
(n = 3132) b
HDP 
(n = 541) b
No HDP 





































Detailed Mode of delivery




Emergency CS in labour
Emergency CS pre labour
























































































































aAdjusted Odds Ratio (for BMI >35, Maternal Age >40 and Nulliparity). Results demonstrating significant differences are highlighted in bold.bValues are shown in n (%) unless 
otherwise stated.
cGrade of Caesarean Section is defined as per the RCOG Classification of Urgency of Caesarean Section 2011.
dElective/ Previous CS/Non-vertex presentation .
eFetal Complications/Non reassuring CTG/ Intrauterine death/Failure to progress.
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Preterm Live Birth (<37 weeks)

























































aAdjusted Odds Ratio (for BMI >35 Kg/m2, Maternal Age >40 and Nulliparity). Results demonstrating significant differences are highlighted in bold.
bValues are shown in n (%) unless otherwise stated 
c56 cases of Miscarriage/Stillbirth were removed leaving 3076 livebirths 
d Reference used is delivery at/after 37 weeks gestation 
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(n = 451) b
No HDP





Preterm Live Birth (<37 weeks)

























































aAdjusted Odds Ratio (for BMI >35 Kg/m2, Maternal Age >40 and Nulliparity). Results demonstrating significant differences are highlighted in bold.bValues are shown in n (%) 
unless otherwise stated 
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d Reference used is delivery at/after 37 weeks gestation. 
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Table 5: Perinatal outcomes entire cohort
Total population 
(n = 3132) b
HDP 
(n = 541) b
No HDP



















LBWc 1537 (49.1) 300 (55.5) 1237 (48.3) 1.3 (1.1-1.6) 1.6 (1.1-2.4)
VLBWd 242 (7.7) 41 (7.6) 201 (7.9) 0.9 (0.7-1.4) 0.9 (0.4-1.8)



























Perinatal Mortality Rate 12.3 3.7 14.1
- -
NICU Admission 1332 (42.5) 266 (49.2) 1067 (41.2) 1.4 (1.1-1.7) 1.2 (0.8-1.8)
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Neonatal Morbidity Composite





























aAdjusted Odds Ratio (for BMI >35 Kg/m2, Maternal Age >40 and Nulliparity. Results demonstrating significant differences are highlighted in bold.
bValues are shown in n (%) unless otherwise stated
cLow Birth Weight (<2500g), 
dVery Low Birth Weight (<1500g), 
eFetal Anomaly includes all anomalies except patent ductus arteriosus (PDA) in a premature infant, 
HDP, hypertensive disorder of pregnancy; SGA, small for gestational age;  IUD, Intrauterine Fetal Demise; NND, Neonatal Death; NICU, Neonatal Intensive Care Unit; TTN, 
Transient tachypnoea of the newborn; RDS, Respiratory Distress syndrome; ROP, Retinopathy of prematurity; CLD, Chronic Lung Disease; IVH, Intraventricular Haemorrhage; 
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Table 6: Perinatal outcomes dichorionic only
Total population 
(n = 2543) b
HDP 
(n = 451) b
No HDP



















LBWc 1163 (45.7) 242 (53.7) 921 (44.3) 1.5 (1.2-1.8) 1.8 (1.2-2.6)
VLBWd 147 (5.8) 32 (7.1) 115 (5.5) 1.3 (0.9-2.0) 0.8 (0.3-1.9)


















Corrected Perinatal Mortality Rate 5.4 2.2 6.2
NICU Admission 1025 (40.3) 214 (20.9) 811 (79.1) 1.4 (1.2-1.8) 1.2 (0.8-1.8)
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aAdjusted Odds Ratio (for BMI >35 Kg/m2, Maternal Age >40 and Nulliparity. Results demonstrating significant differences are highlighted in bold.
 bValues are shown in n (%) unless otherwise stated.
cLow Birth Weight (<2500g).
dVery Low Birth Weight (<1500g).
eFetal Anomaly includes all anomalies except patent ductus arteriosus (PDA) in a premature infant.
HDP, hypertensive disorder of pregnancy; SGA, small for gestational age;  IUD, Intrauterine Fetal Demise; NND, Neonatal Death; NICU, Neonatal Intensive Care Unit; TTN, 
Transient tachypnoea of the newborn; RDS, Respiratory Distress syndrome; ROP, Retinopathy of prematurity; CLD, Chronic Lung Disease; IVH, Intraventricular Haemorrhage; 
NEC, Necrotising enterocolitis; HIE, Hypoxic Ischaemic Encephalaloapthy.
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